ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2589

Searching the Calcinosis Signature: A Case Control Study Analyzing Limited Systemic Sclerosis Female Patients with and Without Calcinosis, Paired by Disease Duration, Age and Body Mass Index

Marilia Sampaio-Barros 1, Lorena Castelo-Branco 1, Liliam Takayama 1, Marco Pontes-Filho 1, Percival Degrava Sampaio-Barros 2 and Rosa Pereira3, 1University of Sao Paulo, Sao Paulo, Brazil, 2Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR, Brazil, Sao Paulo, Brazil, 3Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, Sao Paulo, Brazil

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: systemic sclerosis and calcinosis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Session Title: Systemic Sclerosis & Related Disorders – Clinical Poster III

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Calcinosis usually represents a late manifestation of limited systemic sclerosis (lSSc), inducing chronic calcifications that lead to significant impairment in the quality of life. As an effective treatment for calcinosis in SSc is an unmet need in clinical practice, the identification of risk factors associated with its presence is rather important for the development of therapeutic strategies.

The aim of this study was to compare and analyze clinical aspects and laboratory parameters, including bone metabolism, in female lSSc patients with and without calcinosis, paired by disease duration, age and body mass index (BMI).

Methods: Thirty-six female lSSc patients with calcinosis were compared to 36 female lSSc patients without calcinosis, matched by disease duration, age and BMI. Modified Rodnan skin score (mRSS) was used to determine the extension of the skin involvement. Organ involvement, autoantibodies, bone mineral density (BMD) by DXA and laboratory parameters were analyzed. The past and current treatment modalities were also questioned. Statistical significance was considered if p< 0.05.

Results: Esophageal hypomotility, digital ulcers and interstitial lung disease were the most frequent clinical manifestations of lSSc patients, present in similar frequency in both groups. In univariate analysis, calcinosis was significantly associated with acroosteolysis (69% vs. 22%, p< 0.001), higher modified mRSS (4.28±4.66 vs 1.17±2.50, p< 0.001), higher 25OH vitamin D (24.46±8.15 vs. 20.80±6.60ng/ml, p=0.040) and phosphorus serum levels (3.81±0.41 vs. 3.43±0.45mg/dl; p< 0.001). Antinuclear antibodies (ANA) was positive in 89% in both groups. Anticentromere antibody was frequent (44% and 31%), while positive anti-Scl70 was rare in both groups. Regarding treatment, current use of glucocorticoid was lower in patients with calcinosis compared to patients without calcinosis (8% vs. 28%; p=0.032). Osteoporosis was more frequent in the group with calcinosis (31% vs.17%), although not statistically significant. Multivariate analysis confirmed and quantified the risk for calcinosis: acroosteolysis (OR=12.04; 95% CI:2.73-53.04; p=0.001), mRSS (OR=1.37; 95% CI:1.11-1.69; p=0.003), phosphorus serum levels (OR=5.07; 95% CI:1.06-24.23; p=0.042), and lower glucocorticoid use (OR=0.07; 95% CI:0.007-0.66; p=0.021).

Conclusion: This study showed that lSSc patients with calcinosis present a distinct clinic and biochemical profile, characterized by acroosteolysis, higher mRSS score, higher serum levels of phosphorus and lower glucocorticoid use, when compared to a matched group without calcinosis, paired by disease duration, age, and BMI.


Disclosure: M. Sampaio-Barros, None; L. Castelo-Branco, None; L. Takayama, None; M. Pontes-Filho, None; P. Sampaio-Barros, None; R. Pereira, None.

To cite this abstract in AMA style:

Sampaio-Barros M, Castelo-Branco L, Takayama L, Pontes-Filho M, Sampaio-Barros P, Pereira R. Searching the Calcinosis Signature: A Case Control Study Analyzing Limited Systemic Sclerosis Female Patients with and Without Calcinosis, Paired by Disease Duration, Age and Body Mass Index [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/searching-the-calcinosis-signature-a-case-control-study-analyzing-limited-systemic-sclerosis-female-patients-with-and-without-calcinosis-paired-by-disease-duration-age-and-body-mass-index/. Accessed January 30, 2023.
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/searching-the-calcinosis-signature-a-case-control-study-analyzing-limited-systemic-sclerosis-female-patients-with-and-without-calcinosis-paired-by-disease-duration-age-and-body-mass-index/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences